{"paper_id":"c2c7f15d-cfea-417d-ab19-926920dffe3d","body_text":"Abstract\nWe designed this prospective, randomized controlled animal study to determine the effects of hyperbaric oxygen (HBO) on experimentally induced endometriosis in a rat model. Surgical induction of endometriosis was performed in 40, nonpregnant, female, Wistar-Albino rats at the Experimental Medicine Research Center of Istanbul University (DETAE). Four weeks later, the first and second laparotomies for volume measurement and peritoneal fluid (PF) collection were performed, and the rats were divided randomly into the study and control groups. The study group was exposed to HBO treatment for 6 weeks. Then, a third laparotomy was performed on all of the rats. The volume, histopathologic scores, Ki-67 labeling of the endometriotic implants, and the levels of tumor necrosis factor-α (TNF-α) in the PF were measured. The mean volume of the endometriotic implants in the study group was significantly lower than that of the control group at the end of the study (57.4 ± 12.5 vs 94.6 ± 17.2 mm3). The mean histopathological scores (1.60 ± 0.50 vs 2.42 ± 0.51), Ki-67 immunohistochemical scores (1.50 ± 0.51 vs 2.37 ± 0.49) of the endometriotic implants, and the TNF-α levels (5.33 ± 1.02 vs 8.16 ± 1.76 pg/mL) were significantly lower in the study group than in the control group. Hyperbaric oxygen treatment for 2 hours a day for 6 weeks resulted in significant remission of endometriosis in rats.\nSimilar content being viewed by others\nReferences\nBenson RM, Minter LM, Osborne BA, Granowitz EV. Hyperbaric oxygen inhibits stimulus-induced proinflammatory cytokine synthesis by human blood-derived monocyte-macrophages. Clin Exp Immunol. 2003;134(1):57–62\nFildissis G, Venetsanou K, Myrianthefs P, Karatzas S, Zidianakis V, Baltopoulos G. Whole blood pro-inflammatory cytokines and adhesion molecules post-lipopolysaccharides exposure in hyperbaric conditions. Eur Cytokine Netw. 2004;15(3):217–221\nBrenner I, Shepard RJ, Shek PN. Immune function in hyperbaric environments, diving, and decompression. Undersea Hyper Med. 1999;26(1):27–39\nMurphy SA, Hyams JS, Fisher AB, Root RK. Effects of oxygen exposure on in vitro function of pulmonary alveolar macrophages. J Clin Invest. 1975;56(2):503–511\nInamoto Y, Okuno F, Saito K, et al. Effect of hyperbaric oxygenation on macrophage function in mice. Biochem Biophys Res Comm. 1991;179(2):886–891\nLahat N, Bitterman H, Yaniv N, Kinarty A, Bitterman N. Exposure to hyperbaric oxygen induces tumour necrosis factor-alpha (TNF-a) secretion from rat macrophages. Clin Exp Immunol. 1995;102(3):655–659\nYang Z, Nandi J, Wang J, et al. Hyperbaric oxygenation ameliorates indomethacin-induced enteropathy in rats by modulating TNF-alpha and IL-1beta production. Dig Dis Sci. 2006;51(8):1426–1433\nWu MY, Ho HN. The role of cytokines in endometriosis. Am J Reprod Immunol. 2003;49(3):285–296\nEthridge RT, Hashimoto K, Chung DH, Ehlers RA, Rajaraman S, Evers BM. Selective inhibition of NF-ΚB attenuates the severity of cerulein-induced acute pancreatitis. J Am Coll Surg. 2002;195(4):497–505\nGukovsky I, Gukovskaya AS, Blinman TA, Zaninovic V, Pandol SJ. Early NF kappa B activation is associated with hormone-induced pancreatitis. Am J Physiol. 1998;275(6 pt 1):1402–1414\nKim H, Seo JY, Roh KH, Lim JW, Kim KH. Suppression of NF-ΚB activation and cytokine production by N-acetylcysteine in pancreatic acinar cells. Free Rad Biol Med. 2000;29(7):674–683\nCarswell EA, Old LJ, Kassel RL, Gren S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA. 1975;72(9):3666–3670\nPennica D, Nedwin GE, Hayflick JS, Seeburg PH, Derynck R, Palladino MA. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature. 1984;312(5996):724–729\nLocksley RM, Killen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 2001;104(4):487–501\nChen HL, Yang YP, Hu XL, Yelavarthi KK, Fishback JL, Hunt JC. Tumor necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation. Am J Pathol. 1991;139(2):327–335\nJokhi PP, King A, Loke YW. Cytokine production and cytokine receptor expression by cells of the human first trimester placental-uterine interface. Cytokine. 1997;9(2):126–137\nBornstein SR, Rutkowski H, Vrezas I. Cytokines and steroidogenesis. Mol Cell Endocrinol. 2004;215(1–2):135–141\nWuttke W, Jarry H, Pitzel L, Knoke I, Spiess S. Luteotrophic and luteolytic actions of ovarian peptides. Hum Reprod. 1993;8(suppl 2):141–146\nTerranova PF, Rice VM. Review: cytokine involvement in ovarian processes. Am J Reprod Immunol. 1997;37(1):50–63\nVernon MW, Wilson EA. Studies on the surgical induction of endometriosis in the rat. Fertil Steril. 1985;44(5):684–694\nKeenan JA, Williams-Boyce PK, Massey PJ, Chen TT, Caudle MR. Bukovsky A regression of endometrial explants in a rat model of endometriosis treated with the immune modulators loxoribine and levamisole. Fertil Steril. 1999;72(1):135–141\nHunter S, Langemo DK, Anderson J, Hanson D, Thompson P. Hyperbaric oxygen therapy for chronic wounds. Adv Skin Wound Care. 2010;23(3):116–1169\nVan den Blink B, van der Kleij AJ, Versteeg HH, Peppelenbosch MP. Immunomodulatory effect of oxygen and pressure. Comp Biochem Physiol Physiol. 2002;132(1):193–197\nLuongo C, Imperatore F, Cuzzocrea S, et al. Effects of hyperbaric oxygen exposure on a zymosan-induced shock model. Crit Care Med. 1998;26(12):1972–1976\nYamashita M, Yamashita M. Hyperbaric oxygen treatment attenuates cytokine induction after massive hemorrhage. Am J Physiol Endocrinol Metab. 2000;278(5):811–816\nYang Z, Bosco G, Montante A, Ou X, Camporesi EM. Hyperbaric 02 reduces intestinal schemia-reperfusion-induced TNF-a production and lung neutrophil sequestration. Eur J Appl Physiol. 2001;85(1–2):96–103\nYamauchi N, Harada T, Taniguchi F, Yoshida S, Iwabe T, Terakawa N. Tumor necrosis factor-alpha induced the release of interleukin-6 from endometriotic stromal cells by the nuclear factor-kappaB and mitogen-activated protein kinase pathways. Fertil Steril. 2004;82(suppl 3):1023–1028\nYu X, Li YG, He XW, et al. Hyperbaric oxygen reduces inflammatory response in acute pancreatitis by inhibiting NF- kappaB activation. Eur Surg Res. 2009;42(2):130–135\nYu X, Zhang SD, Hang TQ. The change of pancreatic acinar cell function in murine acute necrotizing pancreatitis. Chin J Gen Surg. 2000;15(5):280–282\nWang F, He YL, Peng DX, Liu MB. Expressions of nuclear factor-kappaB and intercellular adhesion molecule-1 in endometriosis. Di Yi Jun Yi Da Xue Xue Bao. 2005;25(6):703–705\nHorie S, Harada T, Mitsunari M, Taniguchi F, Iwabe T, Terakawa N. Progesterone and progestational compounds attenuate tumor necrosis factor alpha-induced interleukin-8 production via nuclear factor kappa B inactivation in endometriotic stromal cells. Fertil Steril. 2005;83(5):1530–1535\nWieser F, Vigne JL, Ryan I, Hornung D, Djalali S, Taylor RN. Sulindac suppresses nuclear factor-kappaB activation and RANTES gene and protein expression in endometrial stromal cells from women with endometriosis. J Clin Endocrinol Metabol. 2005;90(12):6441–6447\nKuroda K, Kitade M, Kikuchi I, et al. Peritoneal vascular density assessment using narrow-band imaging and vascular analysis software, and cytokine analysis in women with and without endometriosis. J Minim Invasive Gynecol. 2009;3(1):704–710\nKyama CM, Overbergh L, Mihalyi A, et al. Endometrial and peritoneal expression of aromatase, cytokines, and adhesion factors in women with endometriosis. Fertil Steril. 2008;89(2):301–310\nChen Q, Zhou W, Pu D, Li Z, Huang Q, Chen Q. The inhibitory effect of 15-R-LXA4 on experimental endometriosis. Eur J Obstet Gynecol Reprod Biol. 2009;145(2):200–204\nChen QH, Zhou WD, Su ZY, Huang QS, Jiang JN, Chen QX. Change of proinflammatory cytokines follows certain patterns after induction of endometriosis in a mouse model. Fertil Steril. 2009;31(5):217–224\nGogacz M, Bogusiewicz M, Putowski L, et al. Expression of tumor necrosis factor-alpha (TNF-alpha) on peritoneal fluid mononuclear cells in women with endometriosis. Ginekol Pol. 2008;79(1):31–35\nKim HO, Yang KM, Kang IS, et al. Expression of CD44s, vascular endothelial growth factor, matrix metalloproteinase-2 and Ki-67 in peritoneal, rectovaginal and ovarian endometriosis. J Reprod Med. 2007;52(3):207–213\nPark JS, Lee JH, Kim M, Chang HJ, Hwang KJ, Chang KH. Endometrium from women with endometriosis shows increased proliferation activity. Fertil Steril. 2009;92(4):1246–1249\nCelik O, Hascalik S, Elter K, Tagluk ME, Gurates B, Aydin NE. Combating endometriosis by blocking proteasome and nuclear factor-kappaB pathways. Hum Reprod. 2008;23(11):2458–2465\nCimşit M, Uzun G, Yildiz S. Hyperbaric oxygen therapy as an anti-infective agent. Expert Rev Anti Infect Ther. 2009;7(8):1015–1026\nBessereau J, Tabah A, Genotelle N, Français A, Coulange M, Annane D. Middle-ear barotrauma after hyperbaric oxygen therapy. Undersea Hyperb Med. 2010;37(4):203–208\nLee CH, Chen WC, Wu CI, Hsia TC. Tension pneumocephalus: a rare complication after hyperbaric oxygen therapy. Am J Emerg Med. 2009;27(2):251–257\nRivalland G, Mitchell SJ, van Schalkwyk JM. Pulmonary barotrauma and cerebral arterial gas embolism during hyperbaric oxygen therapy. Aviat Space Environ Med. 2010;81(9):888–890\nAuthor information\nAuthors and Affiliations\nCorresponding author\nRights and permissions\nAbout this article\nCite this article\nAydin, Y., Atis, A., Uludag, S. et al. Remission of Endometriosis by Hyperbaric Oxygen Treatment in Rats. Reprod. Sci. 18, 941–947 (2011). https://doi.org/10.1177/1933719111400635\nPublished:\nIssue date:\nDOI: https://doi.org/10.1177/1933719111400635","source_license":"CC0","license_restricted":false}